期刊文献+

恶性胸膜间皮瘤32例临床分析 被引量:4

Malignant pleural mesothelioma in 32 cases
在线阅读 下载PDF
导出
摘要 目的:探讨恶性胸膜间皮瘤的临床特点、诊断、治疗及预后。方法:回顾分析32例恶性胸膜间皮瘤患者的临床资料。结果:恶性胸膜间皮瘤的主要症状为胸痛、呼吸困难、咳嗽;CT及X线主要表现为胸腔积液、胸膜不规则增厚、胸膜结节,其确诊主要依据术后病理、胸膜活检。结论:恶性胸膜间皮瘤以胸痛、呼吸困难、咳嗽为主要症状,胸膜活检为主要确诊方法,以手术为主的综合治疗可延长生存期,改善生活质量。 ObjectiveTo investigate the clinical features,diagnosis,treatment and prognosis of malignant pleural mesothelioma.MethodThe clinical data of 32 cases with malignant pleural mesothelioma were retrospectively analyzed.ResultsThe main manifestations of malignant pleural mesothelioma were chest pain,dyspnea and cough.CT and X-ray mainly showed pleural effusion,irregular pleural thickening and pleural nodule.The diagnosis of malignant pleural mesothelioma was based on postoperative pathological examine and pleural biopsy.ConclusionChest pain,dyspnea and cough are the main symptoms of malignant pleural mesothelioma,pleural biopsy is the main confirmed diagnosis method,the comprehensive treatment based on operation can prolong the life span and improve the living quality.
出处 《吉林医学》 CAS 2010年第34期6194-6195,共2页 Jilin Medical Journal
关键词 恶性胸膜间皮瘤 临床特点 诊治 Malignant pleural mesothelioma Clinical features Diagnosis and treatment
  • 相关文献

参考文献3

二级参考文献18

  • 1[2]Leigh J,Davidson P,Hendrie L,et al.Malignant mesothelioma in Australia,1945-2000[J].AmJInd Med,2002,41(3):188-201.
  • 2孙燕,苏嵋.胸膜间皮留310例综合分析[J].中华结核和呼吸杂志,1989,13(4):216-219.
  • 3[4]Testa J, Carbone M, Hirvonen A, et al. A multi-institutional study confirms the presence and expression of Simian Virus 40 in human malignant mesotheliomas [J]. Cancer Res, 1998, 58(20) :4505-4509.
  • 4[5]Wagner JC, Sleggs EA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province [J]. Br J Ind Med, 1960, 17(10):260.
  • 5[9]Vogelzang NJ. Emerging insight into the biology and therapy of malignant mesothelioma [J]. Semin Oncol, 2002, 29(6): 35-42.
  • 6[10]Hemdon JE, Green MR, Chahinian AP, et al. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B [J]. Chest,1998, 113(3):723-731.
  • 7[11]Strizzi L, Catalano A, Vianale G, et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma [J]. J Pathol , 2001, 193(4):468-475.
  • 8[12]Kindler HL. Malignant pleural mesothelioma[J]. Curr Treat Options Oncol, 2000, 1(4) :313-326.
  • 9[14]Middleton GW, Smith IE, O' Brien ME, et al. Good symptom relief with palliative MVP chemotherapy in malignant mesothelioma [J]. Ann Oncol, 1998, 9(9):269-273.
  • 10[15]Thodtmann R, Depenbrck H, Dumez H, et al. Clinacal and pharmacokinetic phase Ⅰ study of multi-targeted antifolate (LY231514) in combination with cisplatin [J]. J Clin Oncol,1999,17(10):3009-3016.

共引文献3

同被引文献33

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部